A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

FUNCTION OF TERMINAL ILEUM IN PATIENTS WITH YERSINIA-TRIGGERED REACTIVE ARTHRITIS




TekijätSAARIO R, LEINO R, LAHESMAA R, GRANFORS K, TOIVANEN A

KustantajaWILEY

Julkaisuvuosi1992

JournalJournal of Internal Medicine

Tietokannassa oleva lehden nimiJOURNAL OF INTERNAL MEDICINE

Lehden akronyymiJ INTERN MED

Vuosikerta232

Numero1

Aloitussivu73

Lopetussivu76

Sivujen määrä4

ISSN0954-6820

DOIhttps://doi.org/10.1111/j.1365-2796.1992.tb00552.x


Tiivistelmä
In order to study the function of the intestinal epithelium in the terminal ileum, the Schilling test was performed in 10 patients with Yersinia-triggered reactive arthritis, in 10 patients who had recovered from Yersinia enteritis without complications, and in five patients with rheumatoid arthritis treated with non-steroidal anti-inflammatory agents. The Schilling test indicates absorption of vitamin B12 in the terminal ileum, i.e. the area affected by Yersinia and inflamed in patients with reactive arthritis. The findings obtained demonstrate increased uptake through the epithelium in this area of the intestine in patients with Yersinia-triggered reactive arthritis. There are two possible explanations. First, Yersinia infection may have a long-term effect on the gut mucosa. Secondly, some individuals may, at the level of the terminal ileum, show enhanced absorption of vitamin B12 and/or other substances such as microbes or their components, resulting in increased susceptibility to certain infections.



Last updated on 2024-26-11 at 16:07